首页> 美国卫生研究院文献>Disease Markers >GPR87 Is an Overexpressed G-Protein Coupled Receptor in Squamous Cell Carcinoma of the Lung
【2h】

GPR87 Is an Overexpressed G-Protein Coupled Receptor in Squamous Cell Carcinoma of the Lung

机译:GPR87是肺鳞状细胞癌中过表达的G蛋白偶联受体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung cancer is the leading cause of cancer death worldwide. The overall 5-year survival after therapy is about 16% and there is a clear need for better treatment options, such as therapies targeting specific molecular structures. G-protein coupled receptors (GPCRs), as the largest family of cell surface receptors, represent an important group of potential targets for diagnostics and therapy. We therefore used laser capture microdissection and GPCR-focused Affymetrix microarrays to examine the expression of 929 GPCR transcripts in tissue samples of 10 patients with squamous cell carcinoma and 7 with adenocarcinoma in order to identify novel targets in non-small cell lung carcinoma (NSCLC). The relative gene expression levels were calculated in tumour samples compared to samples of the neighbouring alveolar tissue in every patient. Based on this unique study design, we identified 5 significantly overexpressed GPCRs in squamous cell carcinoma, in the following decreasing order of expression: GPR87 > CMKOR1 > FZD10 > LGR4 > P2RY11. All are non-olfactory and GRAFS (glutamate, rhodopsin, adhesion, frizzled/taste2, secretin family) classified. GPR87, LGR4 and CMKOR1 are orphan receptors. GPR87 stands out as a candidate for further target validation due to its marked overexpression and correlation on a mutation-based level to squamous cell carcinoma.
机译:肺癌是全球癌症死亡的主要原因。治疗后的总体5年生存率约为16%,并且显然需要更好的治疗选择,例如针对特定分子结构的疗法。作为最大的细胞表面受体家族,G蛋白偶联受体(GPCR)代表了一组重要的潜在目标,可用于诊断和治疗。因此,我们使用激光捕获显微切割术和以GPCR为重点的Affymetrix微阵列检查了10例鳞状细胞癌和7例腺癌的组织样本中929 GPCR转录本的表达,以鉴定非小细胞肺癌(NSCLC)的新靶标。计算每个患者的肿瘤样品与邻近牙槽组织样品的相对基因表达水平。基于这一独特的研究设计,我们在鳞状细胞癌中鉴定了5个明显过表达的GPCR,其表达顺序依次为:GPR87> CMKOR1> FZD10> LGR4> P2RY11。所有产品均为非嗅觉和GRAFS(谷氨酸盐,视紫红质,黏附,卷曲/味觉2,促胰液素家族)分类。 GPR87,LGR4和CMKOR1是孤儿受体。 GPR87因其显着的过表达和在基于突变的水平上与鳞状细胞癌的相关性而成为进一步靶标验证的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号